Company Encyclopedia
View More
name
Gongdong Medical
605369.SH
Zhejiang Gongdong Medical Technology Co., Ltd. researches, develops, produces, and sells disposable medical consumables in China. Its products include blood collection tubes, needles and needle holders, and sharp containers; cell culture dishes, plates, bottles, flasks, and serological pipette solutions; laboratory consumables, such as petri dishes, centrifuge and cryo tubes, pipette tips, transfer pipettes, cuvettes, and test tubes; urine, stool, and sputum specimen collection containers; epidemic prevention products; vaginal, ear, and anus speculums, and sponge forceps nursing plasticwares; 95kpa specimen container customized solutions; and pharmaceutical packaging products. Zhejiang Gongdong Medical Technology Co., Ltd.
340.02 B
605369.SHMarket value -Rank by Market Cap -/-

Financial Score

10/12/2025 Update
B
Health Care SuppliesIndustry
Industry Ranking13/41
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE6.04%C
    • Profit Margin9.09%B
    • Gross Margin28.57%C
  • Growth ScoreC
    • Revenue YoY2.35%C
    • Net Profit YoY-37.02%D
    • Total Assets YoY7.05%B
    • Net Assets YoY3.46%C
  • Cash ScoreC
    • Cash Flow Margin1100.05%B
    • OCF YoY2.35%C
  • Operating ScoreC
    • Turnover0.55C
  • Debt ScoreA
    • Gearing Ratio18.49%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Gongdong Medical: Shareholding reduction by shareholders holding over 5% leads to a change in equity reaching 1%

    Gongdong Medical announced that its shareholder Taizhou Jinch Investment Management Partnership will reduce its holdings by 540,240 shares through centralized bidding from October 9 to 30, 2025, decreasing its shareholding ratio from 64.21% to 63.96%. This change in equity touches the 1% threshold and is part of the implementation of the reduction plan, which does not affect the company's controlling rights, and the reduction plan has not yet been fully implemented

    Zhitong·
    SH
    605369
    -1.45%
    Zhitong·
    SH
    605369
    -1.45%

    Gongdong Medical's controlling shareholders plan to reduce their holdings by no more than 3%

    According to the announcement from Dolphin Research, Gongdong Medical stated that within three months after the 15 trading days from the date of the announcement, the company's controlling shareholder and actual controller, Shi Huiyong, intends to reduce his holdings by no more than 4.4099 million shares through block trading, and the total number of shares reduced within any consecutive 90 days shall not exceed 2% of the company's total share capital. Jincheng Investment intends to reduce its holdings by no more than 2.2049 million shares through centralized bidding trading, which shall not exceed 1% of the company's total share capital

    Zhitong·
    SH
    605369
    -1.45%
    Zhitong·
    SH
    605369
    -1.45%

    Gongdong Medical: Net profit for the first half of the year was 50.3493 million yuan, a year-on-year decrease of 47.16%

    Gongdong Medical's 2025 semi-annual report shows that in the first half of the year, operating income was 557 million yuan, a year-on-year increase of 0.58%; net profit attributable to the parent company was 50.3493 million yuan, a year-on-year decrease of 47.16%. The decline in net profit was mainly affected by U.S. tariff policies and domestic medical procurement policies, leading to a decrease in the selling prices of some products and a reduction in gross profit. In addition, losses from the investment income of the acquisition of Jindongsheng, fluctuations in the U.S. dollar exchange rate, and a decrease in interest income also impacted net profit

    Zhitong·
    SH
    605369
    -1.45%
    Zhitong·
    SH
    605369
    -1.45%

    Gongdong Medical shareholder Jinchit Investment has cumulatively reduced its holdings by 1.5757 million shares

    According to the Zhitong Finance APP, Gongdong Medical announced that the share reduction plan of its shareholder Jinchi Investment and General Manager Zhong Weifeng has been completed. Jinchi Investment has cumulatively reduced its holdings by 1.5757 million shares through centralized bidding, and Mr. Zhong Weifeng has cumulatively reduced his holdings by 294,900 shares through centralized bidding

    Zhitong·
    SH
    605369
    -1.45%
    Zhitong·
    SH
    605369
    -1.45%

    Gongdong Medical released its first-quarter performance, with a net profit attributable to the parent company of 27.4125 million yuan, a year-on-year decrease of 39.23%

    Gongdong Medical released its Q1 2025 performance report, with operating revenue of 264 million yuan, a year-on-year decrease of 2.74%; net profit attributable to the parent company of 27.4125 million yuan, a year-on-year decrease of 39.23%; net profit after deducting non-recurring gains and losses of 34.744 million yuan, a year-on-year decrease of 20.03%; basic earnings per share of 0.17 yuan/share

    Zhitong·
    SH
    605369
    -1.45%
    Zhitong·
    SH
    605369
    -1.45%
    © 2025 Longbridge｜Disclaimer